United States - English - NLM (National Library of Medicine)

eli lilly and company - baricitinib (unii: isp4442i3y) (baricitinib - unii:isp4442i3y) -

European Union - English - EMA (European Medicines Agency)

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immune sera and immunoglobulins, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

United States - English - NLM (National Library of Medicine)

eli lilly and company - bebtelovimab (unii: 8yl4syr6cu) (bebtelovimab - unii:8yl4syr6cu) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) for the emergency use of bebtelovimab for the treatment of mild-to-moderate coronavirus disease 2019 (covid-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg): - with positive results of direct sars-cov-2 viral testing, and - who are at high risk1 for progression to severe covid-19, including hospitalization or death, and - for whom alternative covid-19 treatment options approved or authorized by fda are not accessible or clinically appropriate [see clinical studies (14.4)] . limitations of authorized use - bebtelovimab is not authorized for treatment of mild-to-moderate covid-19 in geographic regions where infection is likely to have been caused by a non-susceptible sars-cov-2 variant based on available information including variant susceptibility to this drug and regional variant frequency. fda's determination and any updates will be available at: https://www.fda.gov/emergency-pr

Canada - English - Health Canada

pfizer canada ulc - ritonavir; nirmatrelvir - tablet - 100mg; 150mg - ritonavir 100mg; nirmatrelvir 150mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - molnupiravir -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - molnupiravir -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - molnupiravir -

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - molnupiravir 200mg;  ;  ;   - capsule - 200 mg - active: molnupiravir 200mg       excipient: croscarmellose sodium hyprolose hypromellose ink iron oxide red magnesium stearate microcrystalline cellulose titanium dioxide - lagevrio is indicated for the treatment of mild to moderate coronavirus disease 2019 (covid-19) in adults aged 18 years and older who are at increased risk of progressing to severe covid-19, hospitalisation or death.

Canada - English - Health Canada

pfizer canada ulc - ritonavir; nirmatrelvir - tablet - 100mg; 150mg - ritonavir 100mg; nirmatrelvir 150mg

United States - English - NLM (National Library of Medicine)

inflarx gmbh - vilobelimab (unii: f5t0rf9zja) (vilobelimab - unii:f5t0rf9zja) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) for the emergency use of gohibic for the treatment of coronavirus disease 2019 (covid-19) in hospitalized adults when initiated within 48 hours of receiving invasive mechanical ventilation (imv), or extracorporeal membrane oxygenation (ecmo). however, gohibic is not fda-approved for this use. justification for emergency use of drugs during the covid-19 pandemic there is currently an outbreak of coronavirus disease 2019 (covid-19) caused by sars-cov-2, a novel coronavirus. the secretary of hhs has: - determined that there is a public health emergency, or significant potential for a public health emergency, related to covid-191. - declared that circumstances exist justifying the authorization of emergency use of drugs and biological products for the prevention or treatment of covid-192. an eua is a fda authorization for the emergency use of an unapproved product or unapproved use of an approved product (i.e ., drug, bi